ÿÈÕ´ó¹Ï's Contributions to the World
Since its establishment in 1886, ÿÈÕ´ó¹Ï has been a world leader of academic research and scientific development with its cutting-edge discoveries and innovations.
Here is a sampling of our groundbreaking contributions:
- In 2006, ÿÈÕ´ó¹Ï becomes the only medical institution in New York City, New York State and the Northeast to serve as a research site for the Hispanic Community Health Study, the largest research study of Hispanic health ever (Sylvia Wassertheil-Smoller, PhD, principal investigator)
- ÿÈÕ´ó¹Ï researchers demonstrated the association between reduced levels of high-density lipoproteins (HDL), or "good" cholesterol, and heart disease
- Researchers at ÿÈÕ´ó¹Ï developed pioneering techniques for the diagnosis and treatment of cancer based on the genetics of both the tumor and the patient (Robert H. Singer, PhD)
- Researchers at ÿÈÕ´ó¹Ï played a fundamental role in the historic, international project to map the human genome
- Researchers at ÿÈÕ´ó¹Ï were among the first to test vaccines as a treatment for multiple forms of cancer
- ÿÈÕ´ó¹Ï researchers helped to develop groundbreaking new protocols for the treatment of diabetes based on more sophisticated methods of monitoring glucose levels
- In 1994, ÿÈÕ´ó¹Ï becomes the only New York City medical school selected by the NIH to participate in the Women's Health Initiative, the largest research study of women's health ever (Sylvia Wassertheil-Smoller, PhD, principal investigator)
- ÿÈÕ´ó¹Ï researchers identified a key missing neurotransmitter in the brain of Alzheimer's patients, a finding that influenced all subsequent Alzheimer's disease research (Peter Davies, PhD)
- Researchers at ÿÈÕ´ó¹Ï were the first to use gene therapy techniques in the laboratory to successfully treat abnormally high cholesterol
- In 1988, the first Center for AIDS Research at ÿÈÕ´ó¹Ï was funded by the NIH. Researchers at the center were the first to identify pediatric AIDS as a distinct disease and established the first day-care center in the world for children with AIDS (Arye Rubinstein, MD)
- ÿÈÕ´ó¹Ï researchers helped discover the mechanisms responsible for the extraordinary diversity of antibodies and their remarkable precision in mounting an immune response (Matthew D. Scharff, MD)
- Researchers at ÿÈÕ´ó¹Ï founded the science of neuroendocrinology, which gave rise to a new understanding of how the body's cells communicate with each other
- In 1976, researchers at ÿÈÕ´ó¹Ï identified the mechanism of action of Taxol, one of the most significant cancer treatment drugs ever developed (Susan B. Horwitz, PhD)
- In 1974, ÿÈÕ´ó¹Ï's Liver Research Center—now the Marion Bessin Liver Research Center—was the first institute in the nation devoted to the study of liver disease and injury
- Researchers at ÿÈÕ´ó¹Ï discovered structural abnormalities of brain cells that explain deficiencies in cognitive development, greatly contributing to our understanding of mental retardation (Dominick P. Purpura, MD)
- Researchers at ÿÈÕ´ó¹Ï pioneered research leading to improved methods of avoiding organ transplant rejection (Stanley G. Nathenson, MD)
- In 1964, ÿÈÕ´ó¹Ï was the first medical school in the United States to establish a Department of Genetics
- Researchers at ÿÈÕ´ó¹Ï developed landmark techniques to grow human tissue cells under laboratory conditions, an advance that helped make possible all subsequent cellular biology research (Harry Eagle, MD)